TipRanks
Advertisement
Advertisement
Closing Bell Movers: Duolingo up 4% after Evercore upgrade
PremiumThe FlyClosing Bell Movers: Duolingo up 4% after Evercore upgrade
1M ago
SciSparc subsidiary provides update on SCI-210 trial enrollment
Premium
The Fly
SciSparc subsidiary provides update on SCI-210 trial enrollment
1M ago
Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment
Premium
The Fly
Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment
1M ago
SciSparc Subsidiary NeuroThera Wins Japanese Patent for Novel Pain and Fever Therapy
PremiumCompany AnnouncementsSciSparc Subsidiary NeuroThera Wins Japanese Patent for Novel Pain and Fever Therapy
2M ago
SciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center
Premium
Company Announcements
SciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center
2M ago
SciSparc Subsidiary NeuroThera Hits Quantum Milestone in Clinical Data Analytics
Premium
Company Announcements
SciSparc Subsidiary NeuroThera Hits Quantum Milestone in Clinical Data Analytics
2M ago
SciSparc initiates SCI-110 clinical trial in Germany
PremiumThe FlySciSparc initiates SCI-110 clinical trial in Germany
3M ago
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum
Premium
Company Announcements
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum
4M ago
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms
Premium
Company Announcements
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―